SEARCH

SEARCH BY CITATION

References

  • [1]
    Vennerstrom, J.L., Ellis, W.Y., Milhous, W.K., Eaton, R.M. (2001) Antimalarial synergism and antagonism. In: Synergism and Antagonism in Chemotherapy (Chou, T.-C., Rideout, D.C., Eds.), pp.183–222 Academic Press, Inc., New York.
  • [2]
    Marva, E., Chevion, M., Golenser, J. (1991) The effect of free radicals induced by paraquat and copper on the in vitro development of Plasmodium falciparum. Free Radical Res. Commun. 12–13, 137146.
  • [3]
    López-Antuñano, F.J., Schmunis, G.A. (1993) Plasmodia of humans. In: Parasitic Protozoa (Kreier, J.P., Baker, J.R., Eds.), pp.135–266 Academic Press, Inc., San Diego.
  • [4]
    Noedl, H., Wongsrichanalai, C., Wernsdorfer, W.H. (2003) Malaria drug-sensitivity testing: new assays, new perspectives. Trends Parasitol. 19, 175181.
  • [5]
    Elion, G.B., Singer, S., Hitchings, G.H. (1954) Antagonists of nucleic acid derivatives. VIII. Synergism in combinations of biochemically related antimetabolites. J. Biol. Chem. 208, 477488.
  • [6]
    Berenbaum, M.C. (1978) A method for testing for synergy with any number of agents. J. Infect. Dis. 137, 122130.
  • [7]
    Greco, W.R., Park, H.S., Rustum, Y.M. (1990) Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-d-arabinofuranosylcytosine. Cancer Res. 50, 53185327.
  • [8]
    Machado, S.G., Robinson, G.A. (1994) A direct, general approach based on isobolograms for assessing the joint action of drugs in pre-clinical experiments. Stat. Med. 13, 22892309.
  • [9]
    Gavigan, C.S., Machado, S.G., Dalton, J.P., Bell, A. (2001) Analysis of antimalarial synergy between bestatin and endoprotease inhibitors using statistical response-surface modelling. Antimicrob. Agents Chemother. 45, 31753181.
  • [10]
    White, N.J. (1998) Preventing antimalarial drug resistance through combinations. Drug Resist. Update 1, 39.
  • [11]
    Giao, P.T., de Vries, P.J. (2001) Pharmacokinetic interactions of antimalarial agents. Clin. Pharmacokinet. 40, 343373.
  • [12]
    Gupta, S., Thapar, M.M., Wernsdorfer, W.H., Bjorkman, A. (2002) In vitro interactions of artemisinin with atovaquone, quinine, and mefloquine against Plasmodium falciparum. Antimicrob. Agents Chemother. 46, 15101515.
  • [13]
    Foley, M., Tilley, L. (1998) Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents. Pharmacol. Ther. 79, 5587.
  • [14]
    Famin, O., Ginsburg, H. (2002) Differential effects of 4-aminoquinoline-containing antimalarial drugs on hemoglobin digestion in Plasmodium falciparum-infected erythrocytes. Biochem. Pharmacol. 63, 393398.
  • [15]
    Mariga, S.T., Gil, J.P., Sisowath, C., Wernsdorfer, W.H., Bjorkman, A. (2004) Synergism between amodiaquine and its major metabolite, desethylamodiaquine, against Plasmodium falciparum in vitro. Antimicrob. Agents Chemother. 48, 40894096.
  • [16]
    Poe, M. (1976) Antibacterial synergism: a proposal for chemotherapeutic potentiation between trimethoprim and sulfamethoxazole. Science 194, 533535.
  • [17]
    Chulay, J.D., Watkins, W.M., Sixsmith, D.G. (1984) Synergistic antimalarial activity of pyrimethamine and sulphadoxine against Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg. 33, 325330.
  • [18]
    Sirawaraporn, W., Yuthavong, Y. (1986) Potentiating effect of pyrimethamine and sulfadoxine against dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant Plasmodium chabaudi. Antimicrob. Agents Chemother. 29, 899905.
  • [19]
    Hyde, J.E. (2005) Exploring the folate pathway in Plasmodium falciparum. Acta Trop. 94, 191206.
  • [20]
    Wang, P., Brobey, R.K., Horii, T., Sims, P.F., Hyde, J.E. (1999) Utilization of exogenous folate in the human malaria parasite Plasmodium falciparum and its critical role in antifolate drug synergy. Mol. Microbiol. 32, 12541262.
  • [21]
    Wang, P., Wang, Q., Aspinall, T.V., Sims, P.F., Hyde, J.E. (2004) Transfection studies to explore essential folate metabolism and antifolate drug synergy in the human malaria parasite Plasmodium falciparum. Mol. Microbiol. 51, 14251438.
  • [22]
    Meshnick, S.R., Scott, M.D., Lubin, B., Ranz, A., Eaton, J.W. (1990) Antimalarial activity of diethyldithiocarbamate. Potentiation by copper. Biochem. Pharmacol. 40, 213216.
  • [23]
    Fleck, S.L., Robinson, B.L., Peters, W. (1997) The chemotherapy of rodent malaria. LIV. Combinations of ‘Fenozan B07’ (Fenozan-50F), a difluorinated 3,3′-spirocyclopentane 1,2,4-trioxane, with other drugs against drug-sensitive and drug-resistant parasites. Ann. Trop. Med. Parasitol. 91, 3339.
  • [24]
    Vennerstrom, J.L., Ager Jr, A.L., Andersen, S.L., Grace, J.M., Wongpanich, V., Angerhofer, C.K., Hu, J.K., Wesche, D.L. (2000) Assessment of the antimalarial potential of tetraoxane WR 148999. Am. J. Trop. Med. Hyg. 62, 573578.
  • [25]
    Winstanley, P.A. (2000) Chemotherapy for falciparum malaria: the armoury, the problems and the prospects. Parasitol. Today 16, 146153.
  • [26]
    Khan, B., Brandling-Bennett, A.D., Watkins, W.M., Oloo, A.J., Ojoo, P., Koech, D.K. (1991) Plasmodium falciparum sensitivity to erythromycin and 4-aminoquinoline combinations in vitro. Ann. Trop. Med. Parasitol. 85, 215222.
  • [27]
    Pukrittayakamee, S., Prakongpan, S., Wanwimolruk, S., Clemens, R., Looareesuwan, S., White, N.J. (2003) Adverse effect of rifampin on quinine efficacy in uncomplicated falciparum malaria. Antimicrob. Agents Chemother. 47, 15091513.
  • [28]
    Sullivan Jr, D.J., Matile, H., Ridley, R.G., Goldberg, D.E. (1998) A common mechanism for blockade of heme polymerization by antimalarial quinolines. J. Biol. Chem. 273, 3110331107.
  • [29]
    Skinner-Adams, T., Davis, T.M. (1999) Synergistic in vitro antimalarial activity of omeprazole and quinine. Antimicrob. Agents Chemother. 43, 13041306.
  • [30]
    Ursos, L.M., Roepe, P.D. (2002) Chloroquine resistance in the malarial parasite, Plasmodium falciparum. Med. Res. Rev. 22, 465491.
  • [31]
    Canfield, C.J., Pudney, M., Gutteridge, W.E. (1995) Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro. Exp. Parasitol. 80, 373381.
  • [32]
    Looareesuwan, S., Chulay, J.D., Canfield, C.J., Hutchinson, D.B. (1999) Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group. Am. J. Trop. Med. Hyg. 60, 533541.
  • [33]
    Srivastava, I.K., Vaidya, A.B. (1999) A mechanism for the synergistic antimalarial action of atovaquone and proguanil. Antimicrob. Agents Chemother. 43, 13341339.
  • [34]
    Benoit-Vical, F., Robert, A., Meunier, B. (1999) Potentiation of artemisinin activity against chloroquine-resistant Plasmodium falciparum strains by using heme models. Antimicrob. Agents Chemother. 43, 25552558.
  • [35]
    Benoit-Vical, F., Robert, A., Meunier, B. (2000) In vitro and in vivo potentiation of artemisinin and synthetic endoperoxide antimalarial drugs by metalloporphyrins. Antimicrob. Agents Chemother. 44, 28362841.
  • [36]
    Pradines, B., Rolain, J.M., Ramiandrasoa, F., Fusai, T., Mosnier, J., Rogier, C., Daries, W., Baret, E., Kunesch, G., Le Bras, J., Parzy, D. (2002) Iron chelators as antimalarial agents: in vitro activity of dicatecholate against Plasmodium falciparum. J. Antimicrob. Chemother. 50, 177187.
  • [37]
    Pattanapanyasat, K., Kotipun, K., Yongvanitchit, K., Hider, R.C., Kyle, D.E., Heppner, D.G., Walsh, D.S. (2001) Effects of hydroxypyridinone iron chelators in combination with antimalarial drugs on the in vitro growth of Plasmodium falciparum. Southeast Asian J. Trop Med. Public Health 32, 6469.
  • [38]
    Eckstein-Ludwig, U., Webb, R.J., Van Goethem, I.D., East, J.M., Lee, A.G., Kimura, M., O'Neill, P.M., Bray, P.G., Ward, S.A., Krishna, S. (2003) Artemisinins target the SERCA of Plasmodium falciparum. Nature 424, 957961.
  • [39]
    Berry, C. (1999) Proteases as drug targets for the treatment of malaria. In: Proteases of Infectious Agents (Dunn, B.M., Ed.), pp.165–188 Academic Press, New York.
  • [40]
    Bailly, E., Jambou, R., Savel, J., Jaureguiberry, G. (1992) Plasmodium falciparum: differential sensitivity in vitro to E-64 (cysteine protease inhibitor) and Pepstatin A (aspartyl protease inhibitor). J. Protozool. 39, 593599.
  • [41]
    Semenov, A., Olson, J.E., Rosenthal, P.J. (1998) Antimalarial synergy of cysteine and aspartic protease inhibitors. Antimicrob. Agents Chemother. 42, 22542258.
  • [42]
    Meshnick, S.R., Scott, M.D., Lubin, B., Ranz, A., Eaton, J.W. (1990) Antimalarial activity of diethyldithiocarbamate: potentiation by copper. Biochem. Pharmacol. 40, 213216.
  • [43]
    Winter, R.W., Cornell, K.A., Johnson, L.L., Ignatushchenko, M., Hinrichs, D.J., Riscoe, M.K. (1996) Potentiation of the antimalarial agent rufigallol. Antimicrob. Agents Chemother. 40, 14081411.
  • [44]
    Winter, R.W., Ignatushchenko, M., Ogundahunsi, O.A., Cornell, K.A., Oduola, A.M., Hinrichs, D.J., Riscoe, M.K. (1997) Potentiation of an antimalarial oxidant drug. Antimicrob. Agents Chemother. 41, 14491454.
  • [45]
    Murphy, A.D., Lang-Unnasch, N. (1999) Alternative oxidase inhibitors potentiate the activity of atovaquone against Plasmodium falciparum. Antimicrob. Agents Chemother. 43, 651654.
  • [46]
    Jomaa, H., Wiesner, J., Sanderbrand, S., Altincicek, B., Weidemeyer, C., Hintz, M., Turbachova, I., Eberl, M., Zeidler, J., Lichtenthaler, H.K., Soldati, D., Beck, E. (1999) Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science 285, 15731576.
  • [47]
    Wiesner, J., Henschker, D., Hutchinson, D.B., Beck, E., Jomaa, H. (2002) In vitro and in vivo synergy of fosmidomycin, a novel antimalarial drug, with clindamycin. Antimicrob. Agents Chemother. 46, 28892894.
  • [48]
    Biagini, G.A., Richier, E., Bray, P.G., Calas, M., Vial, H., Ward, S.A. Heme binding contributes to antimalarial activity of bis-quaternary ammoniums Antimicrob. Agents Chemother. 47 (2003) 25842589 Erratum in: Antimicrob Agents Chemother, 47, 3376.
  • [49]
    Stead, A.M., Bray, P.G., Edwards, I.G., DeKoning, H.P., Elford, B.C., Stocks, P.A., Ward, S.A. (2001) Diamidine compounds: selective uptake and targeting in Plasmodium falciparum. Mol. Pharmacol. 59, 12981306.
  • [50]
    Ekong, R., Partridge, S.J., Anderson, M.M., Kirby, G.C., Warhurst, D.C., Russell, P.F., Phillipson, J.D. (1991) Plasmodium falciparum: effects of phaeanthine, a naturally-occurring bisbenzylisoquinoline alkaloid, on chloroquine-resistant and -sensitive parasites in vitro, and its influence on chloroquine activity. Ann. Trop. Med. Parasitol. 85, 205213.
  • [51]
    Mariga, S.T., Gil, J.P., Wernsdorfer, W.H., Bjorkman, A. (2005) Pharmacodynamic interactions of amodiaquine and its major metabolite desethylamodiaquine with artemisinin, quinine and atovaquone in Plasmodium falciparum in vitro. Acta Trop. 93, 221231.
  • [52]
    Winstanley, P.A., Mberu, E.K., Szwandt, I.S., Breckenridge, A.M., Watkins, W.M. (1995) In vitro activities of novel antifolate drug combinations against Plasmodium falciparum and human granulocyte CFUs. Antimicrob. Agents Chemother. 39, 948952.
  • [53]
    Yeo, A.E., Seymour, K.K., Rieckmann, K.H., Christopherson, R.I. (1997) Effects of dual combinations of antifolates with atovaquone or dapsone on nucleotide levels in Plasmodium falciparum. Biochem. Pharmacol. 53, 943950.
  • [54]
    Ndounga, M., Basco, L.K., Ringwald, P. (1999) Variabilité de l'activité in vitro du proguanil et du cycloguanil sur les stades érythrocytaires de Plasmodium falciparum en fonction des conditions de culture. Bull Soc. Pathol. Exot. 92, 313316.
  • [55]
    Ekong, R., Warhurst, D.C. (1990) Synergism between arteether and mefloquine or quinine in a multidrug-resistant strain of Plasmodium falciparum in vitro. Trans. R Soc. Trop. Med. Hyg. 84, 757758.
  • [56]
    Jaquet, C., Stohler, H.R., Chollet, J., Peters, W. (1994) Antimalarial activity of the bicyclic peroxide Ro 42-1611 (arteflene) in experimental models. Trop. Med. Parasitol. 45, 266271.
  • [57]
    Fivelman, Q.L., Walden, J.C., Smith, P.J., Folb, P.I., Barnes, K.I. (1999) The effect of artesunate combined with standard antimalarials against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro. Trans. R Soc. Trop. Med. Hyg. 93, 429432.
  • [58]
    Paciorkowski, A., Dai, W.W., Cerami, A., Berger, B.J. (1997) Synergism of cimetidine with anti-malarial agents. J. Parasitol. 83, 960963.
  • [59]
    Bray, P.G., Janneh, O., Raynes, K.J., Mungthin, M., Ginsburg, H., Ward, S.A. (1999) Cellular uptake of chloroquine is dependent on binding to ferriprotoporphyrin IX and is independent of NHE activity in Plasmodium falciparum. J. Cell Biol. 145, 363376.
  • [60]
    Tiffert, T., Ginsburg, H., Krugliak, M., Elford, B.C., Lew, V.L. (2000) Potent antimalarial activity of clotrimazole in in vitro cultures of Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 97, 331336.
  • [61]
    Akompong, T., Eksi, S., Williamson, K., Haldar, K. (2000) Gametocytocidal activity and synergistic interactions of riboflavin with standard antimalarial drugs against growth of Plasmodium falciparum in vitro. Antimicrob. Agents Chemother. 44, 31073111.
  • [62]
    Ohrt, C., Willingmyre, G.D., Lee, P., Knirsch, C., Milhous, W. (2002) Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro. Antimicrob. Agents Chemother. 46, 25182524.
  • [63]
    Kumar, R., Musiyenko, A., Barik, S. The heat shock protein 90 of Plasmodium falciparum and antimalarial activity of its inhibitor, geldanamycin Malar J. 2 (2003) 30.
  • [64]
    Rakotomanga, M., Razakantoanina, V., Raynaud, S., Loiseau, P.M., Hocquemiller, R., Jaureguiberry, G. (2004) Antiplasmodial activity of acetogenins and inhibitory effect on Plasmodium falciparum adenylate translocase. J. Chemother. 16, 350356.
  • [65]
    Jones, K., Ward, S.A. (2002) Biguanide-atovaquone synergy against Plasmodium falciparum in vitro. Antimicrob. Agents Chemother. 46, 27002703.
  • [66]
    Thapar, M.M., Gupta, S., Spindler, C., Wernsdorfer, W.H., Bjorkman, A. (2003) Pharmacodynamic interactions among atovaquone, proguanil and cycloguanil against Plasmodium falciparum in vitro. Trans. R Soc. Trop. Med. Hyg. 97, 331337.
  • [67]
    Nzila, A., Mberu, E., Bray, P., Kokwaro, G., Winstanley, P., Marsh, K., Ward, S. (2003) Chemosensitization of Plasmodium falciparum by probenecid in vitro. Antimicrob. Agents Chemother. 47, 21082112.
  • [68]
    Fivelman, Q.L., Adagu, I.S., Warhurst, D.C. (2004) Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum. Antimicrob. Agents Chemother. 48, 40974102.
  • [69]
    Ye, Z., Van Dyke, K. (1994) Interaction of artemisinin and tetracycline or erythromycin against Plasmodium falciparum in vitro. Parasite 1, 211218.
  • [70]
    Hassan Alin, M., Bjorkman, A., Wernsdorfer, W.H. (1999) Synergism of benflumetol and artemether in Plasmodium falciparum. Am J. Trop. Med. Hyg. 61, 439445.
  • [71]
    Sponer, U., Prajakwong, S., Wiedermann, G., Kollaritsch, H., Wernsdorfer, G., Wernsdorfer, W.H. (2002) Pharmacodynamic interaction of doxycycline and artemisinin in Plasmodium falciparum. Antimicrob. Agents Chemother. 46, 262264.
  • [72]
    Ramharter, M., Noedl, H., Winkler, H., Graninger, W., Wernsdorfer, W.H., Kremsner, P.G., Winkler, S. (2003) In vitro activity and interaction of clindamycin combined with dihydroartemisinin against Plasmodium falciparum. Antimicrob. Agents Chemother. 47, 34943499.
  • [73]
    Gluzman, I.Y., Francis, S.E., Oksman, A., Smith, C.E., Duffin, K.L., Goldberg, D.E. (1994) Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway. J. Clin. Invest. 93, 16021608.
  • [74]
    Dieckmann-Schuppert, A., Franklin, R.M. (1990) Mode of action of tubulozoles against Plasmodium falciparum in vitro. Antimicrob. Agents Chemother. 34, 15291534.
  • [75]
    Jairam, K.T., Havlik, I., Monteagudo, F.S. (1991) Possible mechanism of action of desferrioxamine and 2,2′-bipyridyl on inhibiting the in vitro growth of Plasmodium falciparum (FCR 3 strain). Biochem. Pharmacol. 42, 16331634.
  • [76]
    Pradines, B., Ramiandrasoa, F., Rolain, J.M., Rogier, C., Mosnier, J., Daries, W., Fusai, T., Kunesch, G., Le Bras, J., Parzy, D. (2002) In vitro potentiation of antibiotic activities by a catecholate iron chelator against chloroquine-resistant Plasmodium falciparum. Antimicrob. Agents Chemother. 46, 225228.
  • [77]
    Azas, N., Laurencin, N., Delmas, F., Di, G.C., Gasquet, M., Laget, M., Timon-David, P. (2002) Synergistic in vitro antimalarial activity of plant extracts used as traditional herbal remedies in Mali. Parasitol Res. 88, 165171.
  • [78]
    Hamzah, J., Skinner-Adams, T.S., Davis, T.M. (2003) In vitro antimalarial activity of retinoids and the influence of selective retinoic acid receptor antagonists. Acta Trop. 87, 345353.
  • [79]
    Kumar, R., Adams, B., Musiyenko, A., Shulyayeva, O., Barik, S. (2005) The FK506-binding protein of the malaria parasite, Plasmodium falciparum, is a FK506-sensitive chaperone with FK506-independent calcineurin-inhibitory activity. Mol. Biochem. Parasitol. 141, 163173.
  • [80]
    Peters, W., Robinson, B.L., Milhous, W.K. (1993) The chemotherapy of rodent malaria. LI. Studies on a new 8-aminoquinoline, WR 238,605. Ann. Trop. Med. Parasitol. 87, 547552.
  • [81]
    Fleck, S.L., Robinson, B.L., Peters, W., Thevin, F., Boulard, Y., Glenat, C., Caillard, V., Landau, I. (1997) The chemotherapy of rodent malaria. LIII. ‘Fenozan B07’ (Fenozan-50F), a difluorinated 3,3′-spirocyclopentane 1,2,4-trioxane: comparison with some compounds of the artemisinin series. Ann. Trop. Med. Parasitol. 91, 2532.
  • [82]
    Neerja, J., Puri, S.K. (2004) Plasmodium yoelii: activity of azithromycin in combination with pyrimethamine or sulfadoxine against blood and sporozoite induced infections in Swiss mice. Exp. Parasitol. 107, 120124.